Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEHR NASDAQ:CTKB NASDAQ:LAB NASDAQ:TER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEHRAehr Test Systems$18.20-3.2%$14.69$6.27▼$23.00$562.70M2.351.52 million shs993,536 shsCTKBCytek Biosciences$4.03-1.9%$3.43$2.37▼$7.63$522.89M1.341.05 million shs1.54 million shsLABStandard BioTools$1.31+1.2%$1.23$0.92▼$2.32$489.97M1.321.41 million shs1.28 million shsTERTeradyne$107.47+0.9%$92.38$65.77▼$144.16$16.93B1.724.84 million shs3.18 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEHRAehr Test Systems-3.24%+8.08%+36.95%+115.38%+39.57%CTKBCytek Biosciences-1.95%+10.71%+12.57%+38.01%-20.83%LABStandard BioTools+1.16%+0.38%-4.04%+21.96%-17.41%TERTeradyne+0.95%+3.18%+15.83%+38.81%-5.93%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEHRAehr Test Systems1.4917 of 5 stars0.01.00.00.03.02.51.9CTKBCytek Biosciences2.5396 of 5 stars3.12.00.00.02.84.20.0LABStandard BioTools3.4207 of 5 stars3.53.00.00.03.73.30.6TERTeradyne4.5537 of 5 stars2.33.01.73.43.82.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEHRAehr Test Systems 0.00N/AN/AN/ACTKBCytek Biosciences 2.20Hold$5.6038.96% UpsideLABStandard BioTools 3.00Buy$2.5091.57% UpsideTERTeradyne 2.56Moderate Buy$114.446.48% UpsideCurrent Analyst Ratings BreakdownLatest TER, AEHR, LAB, and CTKB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/31/2025TERTeradyneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$120.00 ➝ $130.007/31/2025TERTeradyneStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$85.00 ➝ $100.007/31/2025TERTeradyneMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$74.00 ➝ $100.007/30/2025TERTeradyneThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$85.007/30/2025TERTeradyneCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy7/21/2025TERTeradyneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$110.00 ➝ $120.007/17/2025LABStandard BioToolsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/17/2025TERTeradyneJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$88.00 ➝ $102.007/10/2025TERTeradyneThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageSell$80.007/9/2025TERTeradyneMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$68.00 ➝ $74.006/24/2025TERTeradyneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$90.00 ➝ $105.00(Data available from 8/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEHRAehr Test Systems$58.97M9.23$0.10 per share174.95$4.13 per share4.41CTKBCytek Biosciences$200.45M2.56$0.03 per share118.44$2.97 per share1.36LABStandard BioTools$174.43M2.84N/AN/A$1.27 per share1.03TERTeradyne$2.82B6.06$4.00 per share26.89$17.84 per share6.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEHRAehr Test Systems-$3.91M-$0.13N/A82.73N/A-6.63%-0.15%-0.13%10/9/2025 (Estimated)CTKBCytek Biosciences-$6.02M-$0.05N/A∞N/A-3.27%-1.66%-1.30%N/ALABStandard BioTools-$138.88M-$0.35N/AN/AN/A-78.24%-22.44%-16.74%8/11/2025 (Estimated)TERTeradyne$542.37M$2.8937.1921.072.2316.59%18.16%13.80%10/22/2025 (Estimated)Latest TER, AEHR, LAB, and CTKB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025LABStandard BioTools-$0.04N/AN/AN/A$39.83 millionN/A7/29/2025Q2 2025TERTeradyne$0.54$0.57+$0.03$0.49$649.02 million$651.80 million7/8/2025Q4 2025AEHRAehr Test Systems-$0.02-$0.01+$0.01-$0.10$14.83 million$14,100.00 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEHRAehr Test SystemsN/AN/AN/AN/AN/ACTKBCytek BiosciencesN/AN/AN/AN/AN/ALABStandard BioToolsN/AN/AN/AN/AN/ATERTeradyne$0.480.45%N/A16.61%1 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEHRAehr Test SystemsN/A5.682.99CTKBCytek BiosciencesN/A5.224.95LABStandard BioToolsN/A6.125.37TERTeradyneN/A2.351.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEHRAehr Test Systems69.69%CTKBCytek Biosciences69.46%LABStandard BioTools53.74%TERTeradyne99.77%Insider OwnershipCompanyInsider OwnershipAEHRAehr Test Systems6.20%CTKBCytek Biosciences10.33%LABStandard BioTools23.16%TERTeradyne0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEHRAehr Test Systems9029.92 million28.06 millionOptionableCTKBCytek Biosciences500127.22 million113.58 millionOptionableLABStandard BioTools620379.82 million291.86 millionOptionableTERTeradyne6,500159.07 million158.82 millionOptionableTER, AEHR, LAB, and CTKB HeadlinesRecent News About These CompaniesBank of Nova Scotia Sells 232,627 Shares of Teradyne, Inc. (NASDAQ:TER)2 hours ago | marketbeat.comPinpoint Asset Management Ltd Has $2.26 Million Stock Holdings in Teradyne, Inc. (NASDAQ:TER)August 8 at 7:56 AM | marketbeat.comIronwood Investment Counsel LLC Lowers Stake in Teradyne, Inc. (NASDAQ:TER)August 8 at 7:06 AM | marketbeat.comPrimecap Management Co. CA Sells 36,560 Shares of Teradyne, Inc. (NASDAQ:TER)August 8 at 5:38 AM | marketbeat.comING Groep NV Has $1.72 Million Stock Holdings in Teradyne, Inc. (NASDAQ:TER)August 7 at 4:34 AM | marketbeat.comTeradyne, Inc. (NASDAQ:TER) Shares Sold by Commerce BankAugust 7 at 4:03 AM | marketbeat.comWestfield Capital Management Co. LP Raises Stock Position in Teradyne, Inc. (NASDAQ:TER)August 6 at 5:38 AM | marketbeat.comEarned Wealth Advisors LLC Buys Shares of 2,657 Teradyne, Inc. (NASDAQ:TER)August 6 at 5:17 AM | marketbeat.comTeradyne (TER) Receives a Buy from Evercore ISIAugust 5, 2025 | theglobeandmail.comTeradyne Second Quarter 2025 Earnings: EPS Misses ExpectationsAugust 5, 2025 | finance.yahoo.comTeradyne’s Earnings Call Highlights AI Compute StrengthAugust 5, 2025 | theglobeandmail.comTeradyne: Potential Growth In The Upcoming Years Might Be Already Priced InAugust 5, 2025 | seekingalpha.comTeradyne Inc. stock underperforms Monday when compared to competitors despite daily gainsAugust 5, 2025 | marketwatch.comTeradyne Unveils Magnum 7H - The Next-Generation Memory Tester for High Bandwidth Memory DevicesAugust 4, 2025 | businesswire.com4,268 Shares in Teradyne, Inc. (NASDAQ:TER) Purchased by Blueshift Asset Management LLCAugust 4, 2025 | marketbeat.comBanque Cantonale Vaudoise Makes New Investment in Teradyne, Inc. (NASDAQ:TER)August 4, 2025 | marketbeat.comTeradyne, Inc. (NASDAQ:TER) Shares Bought by IQ EQ FUND MANAGEMENT IRELAND LtdAugust 4, 2025 | marketbeat.comTeradyne (NASDAQ:TER) Lowered to "Sell" Rating by Wall Street ZenAugust 4, 2025 | americanbankingnews.comCantor Fitzgerald Forecasts Increased Earnings for TeradyneAugust 4, 2025 | marketbeat.comWhat is Northland Capmk's Estimate for Teradyne Q3 Earnings?August 4, 2025 | marketbeat.comWhy Teradyne's 19% Rally Is Just Getting Started...August 3, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesSuper Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?3 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 2025View 3 Stocks Riding the AI Data Center Buildout WaveThese 3 Rare Earth Stocks Are Surging Alongside MP MaterialsBy Leo Miller | July 19, 2025View These 3 Rare Earth Stocks Are Surging Alongside MP MaterialsBigBear.ai: Why a 90% Rally Could Be Just the StartBy Jeffrey Neal Johnson | July 10, 2025View BigBear.ai: Why a 90% Rally Could Be Just the Start3 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 2025View 3 Catalysts Driving Plug Power’s Turnaround CaseTER, AEHR, LAB, and CTKB Company DescriptionsAehr Test Systems NASDAQ:AEHR$18.20 -0.61 (-3.24%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$18.31 +0.11 (+0.63%) As of 08/8/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.Cytek Biosciences NASDAQ:CTKB$4.03 -0.08 (-1.95%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.05 +0.02 (+0.47%) As of 08/8/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Standard BioTools NASDAQ:LAB$1.30 +0.02 (+1.16%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.31 +0.01 (+0.46%) As of 08/8/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Teradyne NASDAQ:TER$107.47 +1.01 (+0.95%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$108.70 +1.23 (+1.14%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications. This segment also provides FLEX test platform systems; J750 test system to address the volume semiconductor devices, including microcontrollers; Magnum platform that tests memory devices, such as flash memory and DRAM; and ETS platform for semiconductor manufacturers, and assembly and test subcontractors in the analog/mixed signal markets. It serves integrated device manufacturers that integrate the fabrication of silicon wafers into their business; fabless companies that outsource the manufacturing of silicon wafers; foundries; and semiconductor assembly and test providers. The System Test segment offers defense/aerospace test instrumentation and systems; storage and system level test systems; and circuit-board test and inspection systems. The Wireless Test segment provides wireless test solutions for silicon validation, wireless module manufacturing, and wireless end device manufacturing under the LitePoint brand. This segment also offers IQxel-MX and IQxel-MW7G series products for edge measurement performance in the manufacturing of connectivity products; IQxstream-5G and IQgig-5G family products to support 4G and 5G technologies; and IQgig-UWB+ for certification and manufacturing test support for ultra wideband products. The Robotics segment provides collaborative robotic arms, autonomous mobile robots, and advanced robotic control software for manufacturing, logistics, and industrial customers. The company was incorporated in 1960 and is headquartered in North Reading, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down DraftKings Posts Record Quarter, Eyes Profitability Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
